Trending Topics
|
Israeli Pancreatic Cancer Treatment Could Extend Lives of 3/4 of Patients
(Jerusalem Post) Maayan Jaffe-Hoffman - 77% of patients suffering from stage IV metastatic pancreatic cancer and treated with a protocol developed by Israeli biopharmaceutical company BioLineRx were able to get their disease under control, according to results of an ongoing study.